Showing results (61-70 of 68) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Scientific Reports|June 15, 2017
Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trialSurendra K Sharma, Kiran Katoch, Rohit Sarin, et al.BMJ Global Health|October 27, 2018
Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in IndiaPatrick K Moonan, Sreenivas A Nair, Reshu Agarwal, et al.BMJ (Clinical Research Ed.)|April 10, 2026
Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial)Manjula Singh, Sindhu Joshi, Vikram Vohra, et al.Plos One|July 7, 2018
Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the Revised National Tuberculosis Control Programme, India: A multi-centric prospective studyBanurekha Velayutham, Vineet Kumar Chadha, Neeta Singla, et al.Science Translational Medicine|March 15, 2019
A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatmentMalvika Verma, Karan Vishwanath, Feyisope Eweje, et al.BMJ (Clinical Research Ed.)|March 2, 2021
A living WHO guideline on drugs to prevent covid-19François Lamontagne, Miriam Stegemann, Arnav Agarwal, et al.BMJ (Clinical Research Ed.)|September 5, 2020
A living WHO guideline on drugs for covid-19Arnav Agarwal, Beverly Hunt, Miriam Stegemann, et al.The Indian Journal of Medical Research|April 9, 2013
Contribution of medical colleges to tuberculosis control in India under the Revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges aheadSurendra K Sharma, Alladi Mohan, L S Chauhan, et al.Pageof 7